Envirobe, Inc

AbbraTech Inc, founded in 2020 in Branford, Connecticut, is a pioneering biotechnology company focused on advancing antibody discovery and engineering. Utilizing their innovative EPIVOLVE technology, they aim to identify antibodies targeting previously inaccessible disease proteins for the treatment of conditions such as cancer and immune disorders. Composed of a team of experienced scientists in antibody engineering, AbbraTech combines advanced methods such as phage display and B cell cloning to tackle challenging antigen targets. Their mission is to collaborate with industry and academic partners to develop next-generation antibody-based therapies that push the boundaries of current medical approaches. Generated from the website

OmniCyte, LLC is a preclinical-stage biotechnology company based in Guilford, CT, dedicated to developing targeted treatments that address unmet needs in cancer therapy. The company is advancing its proprietary ImmunoOncology Platform Technology, which focuses on recombinant targeted immunomodulators and costimulators for various indications including ovarian cancer and small cell lung cancer. With a strong management team and a board of renowned experts in oncology, epidemiology, and biochemistry, OmniCyte is positioned to make significant strides in the cancer treatment landscape. The company has secured funding through various sources, including Connecticut Innovations and translational research grants, to support its innovative research and development efforts. Generated from the website

Propria LLC, located in Branford, CT, specializes in in vitro cardiac contractility testing, focusing on disease models and new therapeutics. The company provides detailed testing services, including comprehensive contractile profiling and functional cardiac reserve analysis, enabling scientists and pharmaceutical companies to better predict human pharmacology. With a commitment to advancing cardiac muscle physiology, Propria has developed human engineered heart tissues (hEHTs) that replicate adult human myocardium properties and isometric twitch kinetics. Their innovative approach and refined tissue design ensure robust, reliable datasets, complemented by expert data analysis from experienced PhD-level scientists. Generated from the website